Equity Research

Matt Phipps Discusses Biotech Stocks With The Wall Street Transcript

In The Wall Street Transcript William Blair’s Matt Phipps shares his outlook on what biotech industry companies he’s most closely monitoring for 2022 and the factors at play influencing his perspective sectorwide.

Read the full story

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news

Our Latest News

Brightly Software Has Agreed to be Acquired by Siemens

William Blair acted as lead financial advisor to Brightly Software, Inc., a portfolio company of Clearlake Capital Group, L.P., in connection with its pending sale to Siemens AG (FRA:SIE) for $1.575 billion of upfront cash consideration, along with $300 million in cash earn-out payments, for a total of $1.875 billion.

Read more

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures